RT-qPCR results (Figure 6B) indicated that the expression levels of FAS, Srebp1, CD36, and Fabp2 were increased in HFD mice, while the CIP treatment clearly improved these changes. This evidence concerns the gene SREBF1 and hereditary sensory and autonomic neuropathy.